Charles H Hodge

US Patent:

20070098644, May 3, 2007

Filed:

Oct 31, 2005

Appl. No.:

11/263723

Inventors:

Jay Ray - Montgomery TX, US
Charles Hodge - Cypress TX, US

Assignee:

Richie's Pharmacy and Medical Supply, Incorporated - Montgomery TX

International Classification:

A61K 9/12
A61K 31/56
A61K 31/16
A01N 45/00
A01N 37/18

US Classification:

424045000, 514171000, 514625000

Abstract:

A method of delivery of a combination therapy to the pulmonary system that includes providing a nebulizer and a fluid comprising a long-acting corticosteroid, a long-acting beta-agonist, and a long-acting anticholinergic in a pharmaceutically acceptable vehicle, and administering the solution to the patient using the nebulizer. The corticosteroid is budesonide, the beta-agonist is formoterol and the anticholinergic is tiotropium in a an aqueous solution, suspension or emulsion suitable for administration with the nebulizer.

US Patent:

20070293460, Dec 20, 2007

Filed:

Jul 31, 2007

Appl. No.:

11/831512

Inventors:

Jay Ray - Montgomery TX, US
Charles Hodge - Cypress TX, US

Assignee:

Richie's Pharmacy and Medical Supply, Incorporated - Montgomery TX

International Classification:

A61K 31/58
A61M 16/00
A61P 11/00
A61P 11/06

US Classification:

514171000, 128200140

Abstract:

A method of delivery of a combination therapy to the pulmonary system that includes providing a nebulizer and an aqueous solution comprising a long-acting corticosteroid, a long-acting beta-agonist, and a long-acting anticholinergic, and administering the solution to the patient using the nebulizer. The corticosteroid is budesonide, the beta-agonist is formoterol and the anticholinergic is tiotropium. A pharmaceutical composition is also described for the treatment of respiratory conditions and diseases comprising a long-acting corticosteroid, a long-acting beta-agonist, and a long-acting anticholinergic, and administering the solution to the patient using the nebulizer.

US Patent:

20130085171, Apr 4, 2013

Filed:

Dec 16, 2011

Appl. No.:

13/328369

Inventors:

Charles D. Hodge - Conroe TX, US

Assignee:

JCDS HOLDINGS, LLC - Conroe TX

International Classification:

A61K 31/135
A61K 31/192
A61P 25/24
A61P 29/00
A61P 21/02
A61P 23/02
A61K 31/195
A61K 31/4168

US Classification:

514401, 514561, 514570, 514647, 514656, 514646

Abstract:

The present embodiments relate to topically delivered medication (compounded) for treatment of pain, inflammation, muscle fatigue, spasms, and/or other ailments. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include a salt load of approximately 30% or greater. The transdermal cream may include a unique base composition such that the transdermal cream may be able to remain stable and avoid degradation for six months or more and capable of effective delivery of active ingredient concentrations exceeding approximately 40% or more of the total formulation weight. The active ingredients may include a nerve depressant, NSAID, muscle relaxant, opiate agonist, local anesthetic, NMDA receptor antagonist, and a tricyclic antidepressant. In one embodiment, the transdermal cream may comprise ketamine HCL, gabapentin, clonidine HCL and baclofen. The transdermal cream may deliver an enhanced topical delivery flux of ketamine via a single transdermal application.

US Patent:

20130165420, Jun 27, 2013

Filed:

Aug 1, 2012

Appl. No.:

13/564467

Inventors:

Charles D. Hodge - Conroe TX, US

Assignee:

JCDS HOLDINGS, LLC - Conroe TX

International Classification:

A61K 31/56
A61P 17/02
A61K 31/569

US Classification:

514171

Abstract:

The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In one aspect, a transdermal cream or gel may provide for the effective administration of multiple medications simultaneously. Preferably, a silicone-based gel may be provided as a base composition and may have a non-zero percentage of silicone or silicone variant. The silicone-based gel may comprise cyclopentasiloxane, polysilicone-11, dimethicone, and C30-45 alkyl cetearyl dimethicone crosspolymer, and include several active ingredients, such as glucocorticoids, antihistamines, and nerve depressants. The silicone-based gel may include a combination of fluticasone, loratadine, and gabapentin. The concentrations of fluticasone and loratadine may be relatively low, while that of gabapentin moderately high. The silicone-based gel may also have one or more local anesthetics, such as prilocaine and/or lidocaine. The silicone-based gel may include additional active ingredients, such as NSAIDs, anticonvulsants, antidepressants, muscle relaxants, and/or other active ingredients.

US Patent:

20130165429, Jun 27, 2013

Filed:

Apr 16, 2012

Appl. No.:

13/448088

Inventors:

Charles D. Hodge - Conroe TX, US

Assignee:

JCDS HOLDINGS, LLC - Conroe TX

International Classification:

A61K 31/5415
A61P 21/02
A61P 25/24
A61P 29/00
A61P 25/08

US Classification:

5142265

Abstract:

The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously; may include low concentrations of local anesthetics, a NSAID, an anticonvulsant, and/or other active ingredients; and may include lidocaine, prilocaine, meloxicam, and lamotrigine and/or topiramate. Alternatively, the transdermal cream may include a lidocaine/prilocaine base cream to which is added a fine powder of one or more ground up medications to form a compounded medication. The compounded medication in powder form may be generated from grinding up tablets of NSAIDs, anticonvulsants, nerve depressants, antidepressants, muscle relaxants, NMDA receptor antagonists, opiate or opioid agonists, and/or other agents. The compounded medication in powder form may include meloxicam, lamotrigine, topiramate, other active ingredients, and DMSO or Sterile Water for Irrigation. In another aspect, the present embodiments relate to methods of compounding medications and transdermal creams or gels.

US Patent:

20130165430, Jun 27, 2013

Filed:

Aug 1, 2012

Appl. No.:

13/564525

Inventors:

Charles D. Hodge - Conroe TX, US

Assignee:

JCDS HOLDINGS, LLC - Conroe TX

International Classification:

A61K 31/5415
A61P 21/02
A61P 25/00
A61P 29/00
A61P 25/08

US Classification:

5142265

Abstract:

The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include low concentrations of local anesthetics, a NSAID, an anticonvulsant, and/or other active ingredients. For instance, the transdermal cream may include lidocaine, prilocaine, meloxicam, and lamotrigine and/or topiramate. Alternatively, the transdermal cream may include a lidocaine/prilocaine base cream to which is added a fine powder of one or more ground up medications to form a compounded medication. The compounded medication in powder form may be generated from grinding up tablets of NSAIDs, anticonvulsants, nerve depressants, antidepressants, muscle relaxants, NMDA receptor antagonists, opiate or opioid agonists, and/or other agents. The compounded medication in powder form may include meloxicam, lamotrigine, topiramate, and/or other active ingredients. In another aspect, the present embodiments relate to methods of compounding medications and transdermal creams or gels.

US Patent:

53462882, Sep 13, 1994

Filed:

Oct 18, 1993

Appl. No.:

8/136865

Inventors:

Charles F. Hodge - Plymouth MI
Syed H. Sarmast - Northville MI
Gerald F. Herbert - Dearborn Heights MI
Dennis M. Sopko - Dearborn Heights MI

Assignee:

Ford Motor Company - Dearborn MI

International Classification:

B60B 700

US Classification:

301 3737

Abstract:

A wheel and cover assembly for an automotive vehicle is provided which includes a road wheel and a cover member aligned road wheel and provides a continuous cushioning member interposed laterally between the cover and the road wheel. The cushioning member is formed as the rubber band L-shaped in cross-section which cooperates with a plurality of circumferentially spaced standoff ribs formed on the laterally inner surface of the cover.

US Patent:

53931289, Feb 28, 1995

Filed:

Oct 18, 1993

Appl. No.:

8/136864

Inventors:

Syed H. Sarmast - Northville MI
Gerald F. Herbert - Dearborn Heights MI
Charles F. Hodge - Plymouth MI

Assignee:

Ford Motor Company - Dearborn MI

International Classification:

B60B 706

US Classification:

301 3734

Abstract:

A wheel and cover assembly for an automotive vehicle is provided which includes a resilient cushioning assembly positioned laterally intermediate a wheel covering disc and a vehicle road wheel. The cushioning assembly consists of a plurality of upstanding channels defined on the laterally inner face of the wheel cover disc into which is inserted a rubber cushioning member which includes a mounting portion for reliable retention by the channel and a ramp portion for effective engagement with the outer annular surface of the wheel.